Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
Akebia Therapeutics (NASDAQ: AKBA), a biopharmaceutical company focused on kidney disease treatments, has announced its participation in the upcoming Jefferies Global Healthcare Conference. The company's executive management will engage in a Fireside Chat scheduled for June 5, 2025, at 8:45 AM EDT in New York City. Investors and interested parties can access the webcast presentation through Akebia's investor relations website at ir.akebia.com after the conference concludes. The conference will run from June 3-5, 2025.
Akebia Therapeutics (NASDAQ: AKBA), un'azienda biofarmaceutica specializzata nei trattamenti per le malattie renali, ha annunciato la sua partecipazione alla prossima Jefferies Global Healthcare Conference. Il management esecutivo della società prenderà parte a una Fireside Chat prevista per il 5 giugno 2025, alle 8:45 AM EDT a New York City. Investitori e interessati potranno seguire la presentazione in webcast sul sito dedicato agli investitori di Akebia, ir.akebia.com, al termine della conferenza. L'evento si svolgerà dal 3 al 5 giugno 2025.
Akebia Therapeutics (NASDAQ: AKBA), una compañía biofarmacéutica centrada en tratamientos para enfermedades renales, ha anunciado su participación en la próxima Jefferies Global Healthcare Conference. La alta dirección de la empresa participará en una Fireside Chat programada para el 5 de junio de 2025, a las 8:45 AM EDT en Nueva York. Los inversores y personas interesadas podrán acceder a la presentación en webcast a través del sitio web de relaciones con inversionistas de Akebia en ir.akebia.com después de que concluya la conferencia. La conferencia se llevará a cabo del 3 al 5 de junio de 2025.
Akebia Therapeutics (NASDAQ: AKBA)는 신장 질환 치료에 중점을 둔 생명공학 회사로, 다가오는 Jefferies Global Healthcare Conference에 참여한다고 발표했습니다. 회사의 경영진은 2025년 6월 5일 오전 8시 45분 EDT에 뉴욕시에서 예정된 Fireside Chat에 참여할 예정입니다. 투자자 및 관심 있는 분들은 회의 종료 후 Akebia의 투자자 관계 웹사이트 ir.akebia.com을 통해 웹캐스트 발표를 시청할 수 있습니다. 이번 컨퍼런스는 2025년 6월 3일부터 5일까지 진행됩니다.
Akebia Therapeutics (NASDAQ : AKBA), une société biopharmaceutique spécialisée dans les traitements des maladies rénales, a annoncé sa participation à la prochaine Jefferies Global Healthcare Conference. La direction exécutive de l'entreprise participera à une Fireside Chat prévue le 5 juin 2025 à 8h45 EDT à New York. Les investisseurs et parties intéressées pourront accéder à la présentation en webcast via le site dédié aux relations investisseurs d'Akebia, ir.akebia.com, après la conférence. L'événement se déroulera du 3 au 5 juin 2025.
Akebia Therapeutics (NASDAQ: AKBA), ein biopharmazeutisches Unternehmen mit Fokus auf Nierenerkrankungen, hat seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference angekündigt. Das Führungsteam des Unternehmens wird an einem Fireside Chat teilnehmen, der für den 5. Juni 2025 um 8:45 Uhr EDT in New York City geplant ist. Investoren und Interessierte können die Webcast-Präsentation nach der Konferenz über die Investor-Relations-Website von Akebia unter ir.akebia.com abrufen. Die Konferenz findet vom 3. bis 5. Juni 2025 statt.
- None.
- None.
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Akebia Executive Management will participate in a Fireside Chat at the Jefferies Global Healthcare Conference on Thursday, June 5 at 8:45 AM EDT.
A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website at https://ir.akebia.com following the conference.
The Jefferies Global Healthcare Conference will take place June 3-5, 2025, in New York City.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
FAQ
When is Akebia Therapeutics (AKBA) presenting at the Jefferies Healthcare Conference 2025?
How can investors watch Akebia Therapeutics' (AKBA) Jefferies conference presentation?
What type of presentation will Akebia Therapeutics (AKBA) give at the Jefferies conference?
What is Akebia Therapeutics' (AKBA) main business focus?
